Search
Now showing items 1-6 of 6
Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study
(Nature Publishing Group, 2015)
The relationship between obesity and the development of cardiovascular disease is well established. However, the underlying mechanisms contributing to vascular disease and increased cardiovascular risk in the obese remain ...
Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years
(Nature Publishing Group, 2015)
Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker that links inflammation with cardiovascular risk. "However, studies linking suPAR and hypertension are scant. First, we determined whether baseline ...
Ethnic-specific relationships between haemostatic and oxidative stress markers in black and white South Africans: the SABPA study
(Taylor & Francis, 2015)
Haemostatic– and oxidative stress markers are associated with increased cardiovascular risk. In the black population, evidence exists that both an imbalance in the haemostatic system and oxidative stress link with the ...
Retinal vessel calibres and haemostasis in black and white South Africans: the SABPA study
(Lippincott Williams & Wilkins, 2015)
Objectives: Retinal arteriolar narrowing associates with hypertension development and indicates increased cardiovascular risk. Evidence on whether the retinal vessel "calibres are related to the haemostatic system is ...
Cornell product relates to albuminuria in hypertensive black adults independently of blood pressure: the SABPA study
(Elsevier, 2015)
Evidence of the relationship between left ventricular hypertrophy and urinary albumin excretion is contradictory and limited in black adults in whom hypertensive heart disease is common. We aimed to investigate the ...
Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population
(Elsevier, 2015)
Background: Elevated inflammatory markers such as C–reactive protein (CRP) and interleukin–6 (IL–6) are wellknown risk factors for cardiovascular mortality. The less familiar marker, soluble urokinase plasminogen activator ...